Myocarditis‐Associated Cardiogenic Shock: A Nationwide Multicenter Study
Myocarditis-associated cardiogenic shock is uncommon yet represents a critically ill population with a higher adjusted in-hospital mortality rate. Future work investigating therapies for this unique patient population is warranted.
Authors
- Israel Safiriyu (ORCID: https://orcid.org/0000-0003-3190-6430)
- Lauren A. Baldassarre (ORCID: https://orcid.org/0000-0003-4173-3449)
- Maria Gabriela Gastanadui
- Miles Shen (ORCID: https://orcid.org/0000-0002-1882-2892)
- Alexander Ambrosini (ORCID: https://orcid.org/0009-0003-5399-2322)
- Talal El Zarif (ORCID: https://orcid.org/0000-0002-4507-2396)
- Avirup Guha (ORCID: https://orcid.org/0000-0003-0253-1174)
- Jennifer M. Kwan (ORCID: https://orcid.org/0000-0002-4715-1848)
- P. Elliott Miller (ORCID: https://orcid.org/0000-0002-0595-1492)
- Mark Jacobs (ORCID: https://orcid.org/0000-0003-4564-0557)
- Andi Shahu
- Sarah C. Hull (ORCID: https://orcid.org/0000-0001-9125-410X)
- Tariq Ali (ORCID: https://orcid.org/0000-0003-0504-403X)
Institutions
- Montefiore Medical Center (US)
- Augusta University (US)
- Yale University (US)
- Augusta University Health (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-11-12
- DOI
- https://doi.org/10.1161/jaha.125.042850
- Primary Topic
- Viral Infections and Immunology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00